Related Experiment Videos
Localized proton MR spectroscopy in infants with urea cycle defect
1Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 PoongNap-Dong, SongPa-Gu, Seoul 138-736, Republic of Korea.
AJNR. American Journal of Neuroradiology
|May 5, 2001
Summary
Urea cycle defects, inborn errors of ammonium metabolism, show distinct patterns on proton MR spectroscopy. This technique aids in diagnosing these metabolic disorders and understanding their underlying pathophysiology.
Area of Science:
- Biochemistry
- Medical Imaging
- Pediatric Metabolism
Background:
- Urea cycle defects are genetic disorders impairing ammonia detoxification.
- These defects lead to hyperammonemia and neurological complications.
- Enzyme deficiencies disrupt the urea synthesis pathway.
Observation:
- Localized short-TE proton MR spectroscopy was used in infants with urea cycle defects.
- Two cases, citrullinemia and ornithine transcarbamylase deficiency, were analyzed.
- Spectroscopy revealed elevated glutamine/glutamate and lipid/lactate signals.
Findings:
- Infants with urea cycle defects exhibit specific metabolic alterations detectable by MR spectroscopy.
- N-acetylaspartate, total creatine, and myo-inositol levels were reduced in citrullinemia.
- Elevated glutamine/glutamate and lipid/lactate complexes were observed in both conditions.
Implications:
- Proton MR spectroscopy is a valuable tool for diagnosing urea cycle enzyme deficiencies.
- This imaging modality enhances understanding of the pathophysiology of these metabolic disorders.
- MR spectroscopy findings can guide clinical management and diagnosis in affected infants.